PK assessment of Mometasone Furoate via a nasal pump spray (QBR112283)

• Research type

  Research Study

• Full title

  Open Label, Randomised Investigation to Assess the Pharmacokinetics of Mometasone Furoate Administered as a New Solution Formulation via a Nasal Pump Spray

• IRAS ID

  95921

• Contact name

  Philip Evans

• Sponsor organisation

  Merck Sharp and Dohme Corp

• Eudract number

  2011-005867-26

• Clinicaltrials.gov Identifier

  N/A

• Research summary

  This study is a comparison of the pharmacokinetic (PK) profile (how well the drug is absorbed into the blood) of Mometasone Furoate administered as a new solution formulation, and as the currently marketed NASONEX nasal spray.

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  12/SC/0011

• Date of REC Opinion

  24 Jan 2012

• REC opinion

  Further Information Favourable Opinion